Sort   by:  
 Page size 
UnknownA JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy.
Not available
S-EPMC3912228 | biostudies-literature
UnknownIdentification of JL1037 as a novel, specific, reversible lysine-specific demethylase 1 inhibitor that induce apoptosis and autophagy of AML cells.
Not available
S-EPMC5458257 | biostudies-literature
UnknownThe G2A Receptor Deficiency Aggravates Atherosclerosis in Rats by Regulating Macrophages and Lipid Metabolism.
Not available
S-EPMC8351205 | biostudies-literature
UnknownFive-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: Recurrence patterns and prediction for potential cure.
Not available
S-EPMC10166917 | biostudies-literature
UnknownProfiling the genome-wide DNA methylation pattern of porcine ovaries using reduced representation bisulfite sequencing.
Not available
S-EPMC4766444 | biostudies-literature
UnknownSingle-cell RNA sequencing reveals that targeting HSP90 suppresses PDAC progression by restraining mitochondrial bioenergetics.
Not available
S-EPMC7930118 | biostudies-literature
ProteomicsThe novel cereblon modulator CC-885 inhibits mitophagy via selective degradation of BNIP3L
Here, by state-of-the-art mass spectrometry-based quantitative proteomic technology, we systematically screened the potential neo-substrates of a novel thalidomide derived cereblon modulator CC-885.
ORGANISM(S): Homo Sapiens 
2020-01-11 | PXD017071 |
UnknownTransarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Not available
S-EPMC9905571 | biostudies-literature
UnknownImmune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
Not available
S-EPMC11090892 | biostudies-literature
UnknownClinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition).
Not available
S-EPMC8974007 | biostudies-literature
Sort   by:  
 Page size